ChemoCentryx, Inc. (CCXI): Price and Financial Metrics
CCXI Price/Volume Stats
| Current price | $51.99 | 52-week high | $52.00 |
| Prev. close | $51.96 | 52-week low | $14.95 |
| Day low | $51.98 | Volume | 2,480,300 |
| Day high | $52.00 | Avg. volume | 1,681,906 |
| 50-day MA | $51.46 | Dividend yield | N/A |
| 200-day MA | $31.96 | Market Cap | 3.71B |
CCXI Stock Price Chart Interactive Chart >
ChemoCentryx, Inc. (CCXI) Company Bio
ChemoCentryx, Inc. focuses on the discovery, development, and commercialization of orally administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States. The company was founded in 1997 and is based in Mountain View, California.
CCXI Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 42.32% |
| 5-year | 43.98% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -41.20% |
| 2020 | 56.56% |
| 2019 | 262.51% |
Continue Researching CCXI
Want to do more research on ChemoCentryx Inc's stock and its price? Try the links below:ChemoCentryx Inc (CCXI) Stock Price | Nasdaq
ChemoCentryx Inc (CCXI) Stock Quote, History and News - Yahoo Finance
ChemoCentryx Inc (CCXI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...